Optimizing Treatment in Patients with ROS1 Rearranged NSCLC

By: Annenberg Center for Health Sciences
Listen for free

  • Summary

  • Greater understanding and implementation of molecular biomarkers in non-small cell lung cancer (NSCLC) have led to improved patient outcomes. However, optimizing therapeutic strategies for patients with a molecular alteration continues to be challenging for the multidisciplinary team. Among these alterations, ROS1 rearrangements are rare, but have important clinical implications.
    Annenberg Center for Health Sciences
    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Introduction and Key Takeaways

    Introduction and Key Takeaways
    Oct 7 2024

    This full educational program can be accessed at no cost here: https://annenberg.net/courses/landingPage.php?courseID=61030
    Show More Show Less
    15 mins

What listeners say about Optimizing Treatment in Patients with ROS1 Rearranged NSCLC

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available